Sign in
4

Changes in Ownership

CUMBERLAND PHARMACEUTICALS INC Filed Acc 0001214659-24-016051

Chairman and CEO acquired 822 shares (code L)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
KAZIMI A J Chairman and CEO 2024-08-01 Other acquisition 10b5-1 +44 $1.47 $65 5,696,925 D: show line 1 in the form
KAZIMI A J Chairman and CEO 2024-08-02 Other acquisition 10b5-1 +40 $1.44 $58 5,696,965 D: show line 2 in the form
KAZIMI A J Chairman and CEO 2024-08-05 Other acquisition 10b5-1 +19 $1.42 $27 5,696,984 D: show line 3 in the form
KAZIMI A J Chairman and CEO 2024-08-06 Other acquisition 10b5-1 +39 $1.46 $57 5,697,023 D: show line 4 in the form
KAZIMI A J Chairman and CEO 2024-08-07 Other acquisition 10b5-1 +44 $1.50 $66 5,697,067 D: show line 5 in the form
KAZIMI A J Chairman and CEO 2024-08-08 Other acquisition 10b5-1 +28 $1.45 $41 5,697,095 D: show line 6 in the form
KAZIMI A J Chairman and CEO 2024-08-12 Other acquisition 10b5-1 +25 $1.43 $36 5,697,120 D: show line 7 in the form
KAZIMI A J Chairman and CEO 2024-08-13 Other acquisition 10b5-1 +70 $1.43 $100 5,697,190 D: show line 8 in the form
Loading xslF345X05/marketforms-66911.xml…